Methyl 1-(2-hydroxyethyl)-4-[(8-methyl-3-oxo-4H-1,4-benzoxazin-6-yl)amino]-5-oxo-2H-pyrrole-3-carboxylate
C17H19N3O6 — CID 168561008
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 1-(2-hydroxyethyl)-4-[(8-methyl-3-oxo-4H-1,4-benzoxazin-6-yl)amino]-5-oxo-2H-pyrrole-3-carboxylate
Methyl 1-(2-hydroxyethyl)-4-[(8-methyl-3-oxo-4H-1,4-benzoxazin-6-yl)amino]-5-oxo-2H-pyrrole-3-carboxylate (PubChem CID 168561008) has the molecular formula C17H19N3O6 and a molecular weight of 361.35 g/mol. Its IUPAC name is methyl 1-(2-hydroxyethyl)-4-[(8-methyl-3-oxo-4H-1,4-benzoxazin-6-yl)amino]-5-oxo-2H-pyrrole-3-carboxylate.
Molecular Properties
| Compound Name | Methyl 1-(2-hydroxyethyl)-4-[(8-methyl-3-oxo-4H-1,4-benzoxazin-6-yl)amino]-5-oxo-2H-pyrrole-3-carboxylate |
|---|---|
| PubChem CID | 168561008 |
| Molecular Formula | C17H19N3O6 |
| Molecular Weight | 361.35 g/mol |
| Exact Mass | 361.13 |
| IUPAC Name | methyl 1-(2-hydroxyethyl)-4-[(8-methyl-3-oxo-4H-1,4-benzoxazin-6-yl)amino]-5-oxo-2H-pyrrole-3-carboxylate |
| SMILES | COC(=O)C1=C(Nc2cc(C)c3c(c2)NC(=O)CO3)C(=O)N(CCO)C1 |
| InChI | InChI=1S/C17H19N3O6/c1-9-5-10(6-12-15(9)26-8-13(22)19-12)18-14-11(17(24)25-2)7-20(3-4-21)16(14)23/h5-6,18,21H,3-4,7-8H2,1-2H3,(H,19,22) |
| InChIKey | LWKUOTAOFSWRNM-UHFFFAOYSA-N |
| XLogP | -0.00 |
| TPSA | 117.20 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 361.35 |
| LogP ≤ 5 | -0.00 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 168561008 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.